Cargando…
Schizophrenia genomics and proteomics: are we any closer to biomarker discovery?
The field of proteomics has made leaps and bounds in the last 10 years particularly in the fields of oncology and cardiovascular medicine. In comparison, neuroproteomics is still playing catch up mainly due to the relative complexity of neurological disorders. Schizophrenia is one such disorder, bel...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2627915/ https://www.ncbi.nlm.nih.gov/pubmed/19128481 http://dx.doi.org/10.1186/1744-9081-5-2 |